Extendicare Price To Sales Ratio from 2010 to 2024
EXE Stock | CAD 10.33 0.03 0.29% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 0.4675991 | Current Value 0.43 | Quarterly Volatility 0.17636452 |
Check Extendicare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Extendicare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 45.5 M, Interest Expense of 20.5 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 0.43, Dividend Yield of 0.0746 or PTB Ratio of 7.29. Extendicare financial statements analysis is a perfect complement when working with Extendicare Valuation or Volatility modules.
Extendicare | Price To Sales Ratio |
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving together with Extendicare Stock
Moving against Extendicare Stock
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.